The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Onconova has submitted an application with the NIAID, with the goal of obtaining funding from the NIH to conduct human studies with rigosertib in ...
read more
MediciNova announced an agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine using BC-PIV, a human parainfluenza ...
read more
AstraZeneca Pharmaceuticals
AstraZeneca’s Calquence has been recommended for marketing authorization in the EU for the treatment of adult patients with chronic lymphocytic ...
read more
Ampio Pharmaceuticals is actively working on the development of therapies for patients infected with the SARS-CoV-2 virus (COVID-19).
read more
The FDA published the proposed rule, Annual Summary Reporting Requirements Under the Right to Try Act.
read more
MyoKardia announced the FDA has granted Breakthrough Therapy Designation to mavacamten, a novel, oral, allosteric modulator of cardiac myosin, for the...
read more
miRagen announced that the FDA has granted orphan drug designation to cobomarsen, for the treatment of T-cell lymphoma.
read more
Carisma announced the FDA has cleared an IND application for CT-0508, an anti-human epidermal growth factor receptor 2 targeted chimeric antigen ...
read more
Averitas Pharma has received FDA approval for QUTENZA 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of...
read more
ATAI Life Sciences announced the launch of Viridia Life Sciences, a wholly-owned subsidiary developing novel formulations of DMT to treat a variety of...
read more
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
read more
Sorrento received clearance from the FDA to initiate a Phase 2 trial of Abivertinib in patients with COVID-19 who have moderate to severe pulmonary ...
read more
Moleculin Biotech announced a second round of independent laboratory testing has confirmed the antiviral activity of WP1122 against coronavirus.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Heron announced the initiation of a Phase 2 clinical study evaluating CINVANTI injectable emulsion in early hospitalized patients with COVID-19.
read more